TTNNF yields 0.78% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TTNNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TTNNF + MRK for your $10,000?
Toho Titanium Co., Ltd. manufactures and sells titanium metals, catalysts for propylene polymerization, and electronic materials in Japan. It offers titanium metals, such as titanium sponge, titanium ingots, titanium powder, and titanium products. The company also provides propylene polymerization catalysts for producing polypropylene. In addition, it offers electronic materials, including titanium dioxide for use in multi-layered ceramic capacitors (MLCC), positive temperature coefficient thermistors, dielectric filters, and piezo injector products, as well as an additive for optical lenses, and medicines and food; and ultra-fine nickel powder for use as an internal electrodes of MLCCs. Further, the company offers chemicals, such as titanium tetrachloride for the manufacture of titanium sponge, high purity titanium dioxide, barium titanate, polymerization catalyst, and titanium tetrachloride aqueous solutions; titanium tetrachloride aqueous solutions for use in cosmetics, pigments, and barium titanate applications; and potassium titanates. Additionally, it provides lanthanum lithium titanate ceramics for next generation battery application; and WEBTi, a porous titanium sheet for use in filter, electrode, noise absorber, and photocatalyst applications. The company was incorporated in 1948 and is headquartered in Chigasaki, Japan.
Full TTNNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.